Agios Pharmaceuticals, Inc. ( AGIO) - Stock Earnings
AGIO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -103.4 million USD | 12.9 million USD |
| 2025Q4 | -108.0 million USD | 20.0 million USD |
| 2026Q1 | -99.1 million USD | 20.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AGIO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -352.1 million USD | 26.8 million USD |
| 2024 | 673.7 million USD | 36.5 million USD |
| 2025 | -412.8 million USD | 54.0 million USD |
| 2026 Est. | — | — |
AGIO
Price: $31.82
52 week price:
Earnings Per Share: -7.26 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 44002
Ebitda: -88.5 millionMarket Capitalization: 1.7 billion